PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cmrPermissionsJournals.ASM.orgJournalCMR ArticleJournal InfoAuthorsReviewers
 
Clin Microbiol Rev. 1997 April; 10(2): 298–319.
PMCID: PMC172921

Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Abstract

Over 850 Leishmania-human immunodeficiency virus (HIV) coinfection cases have been recorded, the majority in Europe, where 7 to 17% of HIV-positive individuals with fever have amastigotes, suggesting that Leishmania-infected individuals without symptoms will express symptoms of leishmaniasis if they become immunosuppressed. However, there are indirect reasons and statistical data demonstrating that intravenous drug addiction plays a specific role in Leishmania infantum transmission: an anthroponotic cycle complementary to the zoonotic one has been suggested. Due to anergy in patients with coinfection, L. infantum dermotropic zymodemes are isolated from patient viscera and a higher L. infantum phenotypic variability is seen. Moreover, insect trypanosomatids that are currently considered nonpathogenic have been isolated from coinfected patients. HIV infection and Leishmania infection each induce important analogous immunological changes whose effects are multiplied if they occur concomitantly, such as a Th1-to-Th2 response switch; however, the consequences of the viral infection predominate. In fact, a large proportion of coinfected patients have no detectable anti-Leishmania antibodies. The microorganisms share target cells, and it has been demonstrated in vitro how L. infantum induces the expression of latent HIV-1. Bone marrow culture is the most useful diagnostic technique, but it is invasive. Blood smears and culture are good alternatives. PCR, xenodiagnosis, and circulating-antigen detection are available only in specialized laboratories. The relationship with low levels of CD4+ cells conditions the clinical presentation and evolution of disease. Most patients have visceral leishmaniasis, but asymptomatic, cutaneous, mucocutaneous, diffuse cutaneous, and post-kala-azar dermal leishmaniasis can be produced by L. infantum. The digestive and respiratory tracts are frequently parasitized. The course of coinfection is marked by a high relapse rate. There is a lack of randomized prospective treatment trials; therefore, coinfected patients are treated by conventional regimens. Prophylactic therapy is suggested to be helpful in preventing relapses.

Full Text

The Full Text of this article is available as a PDF (275K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Addy M, Nandy A. Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull World Health Organ. 1992;70(3):341–346. [PubMed]
  • Adhya S, Chatterjee M, Hassan MQ, Mukherjee S, Sen S. Detection of Leishmania in the blood of early kala-azar patients with the aid of the polymerase chain reaction. Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):622–624. [PubMed]
  • Aebischer T, Moody SF, Handman E. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect Immun. 1993 Jan;61(1):220–226. [PMC free article] [PubMed]
  • Akuffo H, Dietz M, Teklemariam S, Tadesse T, Amare G, Berhan TY. The use of itraconazole in the treatment of leishmaniasis caused by Leishmania aethiopica. Trans R Soc Trop Med Hyg. 1990 Jul-Aug;84(4):532–534. [PubMed]
  • Albrecht H, Stellbrink HJ, Gross G, Berg B, Helmchen U, Mensing H. Treatment of atypical leishmaniasis with interferon gamma resulting in progression of Kaposi's sarcoma in an AIDS patient. Clin Investig. 1994 Dec;72(12):1041–1047. [PubMed]
  • Altés J, Salas A, Llompart A, Obrador A. Small intestinal involvement in visceral leishmaniasis. Am J Gastroenterol. 1991 Sep;86(9):1283–1283. [PubMed]
  • Altés J, Salas A, Riera M, Udina M, Galmés A, Balanzat J, Ballesteros A, Buades J, Salvá F, Villalonga C. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS. 1991 Feb;5(2):201–207. [PubMed]
  • Alvar J. Leishmaniasis and AIDS co-infection: the Spanish example. Parasitol Today. 1994 Apr;10(4):160–163. [PubMed]
  • Alvar J, Jiménez M. Could infected drug-users be potential Leishmania infantum reservoirs? AIDS. 1994 Jun;8(6):854–854. [PubMed]
  • Alvar J, Gutiérrez-Solar B, Molina R, López-Velez R, Garcia-Camacho A, Martinez P, Laguna F, Cercenado E, Galmes A. Prevalence of Leishmania infection among AIDS patients. Lancet. 1992 Jun 6;339(8806):1427–1427. [PubMed]
  • Alvar J, Verdejo J, Osuna A, Nájera R. Visceral leishmaniasis in a patient seropositive for HIV. Eur J Clin Microbiol. 1987 Oct;6(5):604–606. [PubMed]
  • Andreo JA, Vivancos F, Serrano P, Soriano J. Leishmaniasis visceral con respuesta parcial al ketoconazol en un paciente con anticuerpos antivirus de la inmunodeficiencia humana positivos. Med Clin (Barc) 1991 Oct 12;97(12):476–477. [PubMed]
  • Antezana G, Zeballos R, Mendoza C, Lyevre P, Valda L, Cardenas F, Noriega I, Ugarte H, Dedet JP. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol. Trans R Soc Trop Med Hyg. 1992 Jan-Feb;86(1):31–33. [PubMed]
  • Antunes F, Carvalho C, Tavares L, Botas J, Forte M, del Rio AM, Dutschmann L, Costa A, Abranches P, Pereira CS, et al. Visceral leishmaniasis recrudescence in a patient with AIDS. Trans R Soc Trop Med Hyg. 1987;81(4):595–595. [PubMed]
  • de Rossell RA, de Duran RJ, Rossell O, Rodríguez AM. Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):251–253. [PubMed]
  • Badaró R, Carvalho EM, Rocha H, Queiroz AC, Jones TC. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet. 1986 Mar 22;1(8482):647–649. [PubMed]
  • Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD., Jr New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis. 1986 Dec;154(6):1003–1011. [PubMed]
  • Badaro R, Johnson WD., Jr The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis. J Infect Dis. 1993 Mar;167 (Suppl 1):S13–S17. [PubMed]
  • Balslev U, Jonsbo F, Junge J, Bentsen KD. Tre tilfaelde af visceral leishmaniasis: det ene hos en HIV-positiv mand. Ugeskr Laeger. 1991 May 27;153(22):1591–1592. [PubMed]
  • Barberá JR, Capdevila JA, Fontova MJ, Ocaña I. Leishmaniasis oral en un paciente con el virus de la inmunodeficiencia humana. Med Clin (Barc) 1994 Oct 15;103(12):477–477. [PubMed]
  • Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS. 1994 Jun;8(6):757–762. [PubMed]
  • Barrio J, Lecona M, Cosin J, Olalquiaga FJ, Hernanz JM, Soto J. Leishmania infection occurring in herpes zoster lesions in an HIV-positive patient. Br J Dermatol. 1996 Jan;134(1):164–166. [PubMed]
  • Belazzoug S, Lanotte G, Maazoun R, Pratlong F, Rioux JA. Un nouveau variant enzymatique de Leishmania infantum Nicolle, 1908, agent de la leishmaniose cutanée du nord de l'Algérie. Ann Parasitol Hum Comp. 1985;60(1):1–3. [PubMed]
  • Belda Mira A, Díaz Sánchez F, Martínez García B, Gonzalvo Bellver E, Antón Crespo V, Redón Mas J. Leishmaniasis visceral y SIDA. A propósito de dos casos con diseminación cutánea. An Med Interna. 1994 Aug;11(8):398–400. [PubMed]
  • Berenguer J, Moreno S, Cercenado E, Bernaldo de Quirós JC, García de la Fuente A, Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med. 1989 Jul 15;111(2):129–132. [PubMed]
  • Berhe N, Hailu A, Gemetchu T. Human immunodeficiency virus and recurrence of cutaneous leishmaniasis long after healed localized cutaneous leishmaniasis due to Leishmania aethiopica. Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):400–401. [PubMed]
  • Berhe N, Hailu A, Wolday D, Negesse Y, Cenini P, Frommel D. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):205–207. [PubMed]
  • Bernard E, Rodot S, Michiels JF, Politano S, Le Fichoux Y, Dellamonica P. Leishmaniose viscérale au cours du syndrome immunodéficitaire acquis. Presse Med. 1988 May 7;17(17):872–872. [PubMed]
  • Bernier R, Turco SJ, Olivier M, Tremblay M. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol. 1995 Nov;69(11):7282–7285. [PMC free article] [PubMed]
  • Bettini S, Gramiccia M, Gradoni L, Biggio P, Loi R, Cottoni F, Pau M, Atzeni MC. Leishmaniasis in Sardinia. IV. Epidemiological appraisal of cutaneous leishmaniasis and biochemical characterization of isolates. J Trop Med Hyg. 1990 Aug;93(4):262–269. [PubMed]
  • Bettini S, Gramiccia M, Gradoni L, Pozio E, Mugnai S, Maroli M. Leishmaniasis in Tuscany (Italy): VIII. Human population response to leishmanin in the focus of Monte Argentario (Grosseto) and epidemiological evaluation. Ann Parasitol Hum Comp. 1983;58(6):539–547. [PubMed]
  • Biggar RJ, Goedert JJ, Hoofnagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med. 1987 Mar 5;316(10):630–631. [PubMed]
  • Bissuel F, Leport C, Perronne C, Longuet P, Vilde JL. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med. 1994 Nov;236(5):529–535. [PubMed]
  • Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis. 1987 Jan-Feb;9 (Suppl 1):S57–S63. [PubMed]
  • Borthwick NJ, Bofill M, Gombert WM, Akbar AN, Medina E, Sagawa K, Lipman MC, Johnson MA, Janossy G. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS. 1994 Apr;8(4):431–441. [PubMed]
  • Borzoni F, Gradoni L, Gramiccia M, Maccioni A, Valdes E, Loddo S. A case of lingual and palatine localization of a viscerotropic Leishmania infantum zymodeme in Sardinia, Italy. Trop Med Parasitol. 1991 Sep;42(3):193–194. [PubMed]
  • Botet Fregola J, Portús Vinyeta M. La Leishmaniosis en la España peninsular. Revisión histórico-bibliográfica (1912-1985). Rev Sanid Hig Publica (Madr) 1993 Jul-Aug;67(4):255–266. [PubMed]
  • Broeckaert-van Orshoven A, Michielsen P, Vandepitte J. Fatal leishmaniasis in renal-transplant patient. Lancet. 1979 Oct 6;2(8145):740–741. [PubMed]
  • Burns JM, Jr, Shreffler WG, Benson DR, Ghalib HW, Badaro R, Reed SG. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):775–779. [PubMed]
  • Cabié A, Matheron S, Leprètre A, Bouchaud O, Deluol AM, Coulaud JP. Leishmaniose viscérale au cours de l'infection par le VIH. Une infection opportuniste à part entière. Presse Med. 1992 Oct 24;21(35):1658–1662. [PubMed]
  • Cacopardo B, Nigro L, Preiser W, Famá A, Satariano MI, Braner J, Celesia BM, Weber B, Russo R, Doerr HW. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg. 1996 Jul-Aug;90(4):434–435. [PubMed]
  • Campino L, Santos-Gomes G, Pratlong F, Dedet JP, Abranches P. HIV-Leishmania co-infection in Portugal: isolation of Leishmania infantum MON-24. Trans R Soc Trop Med Hyg. 1994 Jul-Aug;88(4):394–394. [PubMed]
  • Cánovas DL, Carbonell J, Torres J, Altés J, Buades J. Laryngeal leishmaniasis as initial opportunistic disease in HIV infection. J Laryngol Otol. 1994 Dec;108(12):1089–1092. [PubMed]
  • Carbonell Casasús J, Cánovas Llorens DL, Soler Vilarrasa R, Mas Mercant S. Leishmaniasis en O.R.L. An Otorrinolaringol Ibero Am. 1995;22(2):139–149. [PubMed]
  • Cardeñosa N, Riera C, Cortés P, March F, Muñoz C, Portús M, Prats G. Detection and characterization by immunoblot analysis of potentially diagnostic Leishmania infantum polypeptides in human visceral leishmaniasis. Parasite Immunol. 1995 Oct;17(10):509–516. [PubMed]
  • CASARES MATEOS E. [Contribution to the study of the focus of canine leishmaniasis of Madrid (its relations to human forms)]. Rev Sanid Hig Publica (Madr) 1961 Mar-Apr;35:241–250. [PubMed]
  • Cenini P, Berhe N, Hailu A, Frommel D. Mononuclear cell subpopulations in human immunodeficiency virus (HIV)-positive versus HIV-negative patients with visceral leishmaniasis. J Infect Dis. 1994 Mar;169(3):707–708. [PubMed]
  • Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med. 1994 Apr 1;179(4):1361–1366. [PMC free article] [PubMed]
  • Chenoweth CE, Singal S, Pearson RD, Betts RF, Markovitz DM. Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion. Chest. 1993 Feb;103(2):648–649. [PubMed]
  • Chulay JD, Bryceson AD. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg. 1983 May;32(3):475–479. [PubMed]
  • Chulay JD, Adoyo MA, Githure JI. Leishmania donovani parasitaemia in Kenyan visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1985;79(2):218–222. [PubMed]
  • Chunge CN, Gachihi G, Muigai R, Wasunna K, Rashid JR, Chulay JD, Anabwani G, Oster CN, Bryceson AD. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans R Soc Trop Med Hyg. 1985;79(5):715–718. [PubMed]
  • Chunge CN, Owate J, Pamba HO, Donno L. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans R Soc Trop Med Hyg. 1990 Mar-Apr;84(2):221–225. [PubMed]
  • CLARK TB, KELLEN WR, LINDEGREN JE, SMITH TA. THE TRANSMISSION OF CRITHIDIA FASCICULATA LEGER 1902 IN CULISETA INCIDENS (THOMSON). J Protozool. 1964 Aug;11:400–402. [PubMed]
  • Clerici M, Shearer GM. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993 Mar;14(3):107–111. [PubMed]
  • Cnudde F, Raccurt C, Boulard F, Terron-Aboud B, Nicolas M, Juminer B. Diffuse cutaneous leishmaniasis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies. AIDS. 1994 Apr;8(4):559–560. [PubMed]
  • Cohen C, Corazza F, De Mol P, Brasseur D. Leishmaniasis acquired in Belgium. Lancet. 1991 Jul 13;338(8759):128–128. [PubMed]
  • De Colmenares M, Portus M, Riera C, Gallego M, Aisa MJ, Torras S, Munoz C. Short report: detection of 72-75-kD and 123-kD fractions of Leishmania antigen in urine of patients with visceral leishmaniasis. Am J Trop Med Hyg. 1995 May;52(5):427–428. [PubMed]
  • Condom MJ, Clotet B, Sirera G, Milla F, Foz M. Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS) Ann Intern Med. 1989 Nov 1;111(9):767–768. [PubMed]
  • Coutinho SG, Da-Cruz AM, de Oliveira MP, Mendonca SC, Bertho AL, De Luca P. CD4+ and CD8+ T cell immune responses of immunocompetent and immunocompromised (AIDS) patients with American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz. 1996 May-Jun;91(3):381–384. [PubMed]
  • Cozon G, Greenland T, Revillard JP. Profound CD4+ lymphocytopenia in the absence of HIV infection in a patient with visceral leishmaniasis. N Engl J Med. 1990 Jan 11;322(2):132–132. [PubMed]
  • Da-Cruz AM, Conceiço-Silva F, Bertho AL, Coutinho SG. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect Immun. 1994 Jun;62(6):2614–2618. [PMC free article] [PubMed]
  • Da-Cruz AM, Machado ES, Menezes JA, Rutowitsch MS, Coutinho SG. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):511–512. [PubMed]
  • Datry A, Similowski T, Jais P, Rosenheim M, Katlama C, Maheu E, Kazaz S, Fassin D, Danis M, Gentilini M. AIDS-associated leishmaniasis: an unusual gastro-duodenal presentation. Trans R Soc Trop Med Hyg. 1990 Mar-Apr;84(2):239–240. [PubMed]
  • Daudén E, Peñas PF, Rios L, Jimenez M, Fraga J, Alvar J, García-Diez A. Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS. J Am Acad Dermatol. 1996 Aug;35(2 Pt 2):316–319. [PubMed]
  • Davidson RN, Di Martino L, Gradoni L, Giacchino R, Russo R, Gaeta GB, Pempinello R, Scott S, Raimondi F, Cascio A, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med. 1994 Feb;87(2):75–81. [PubMed]
  • Davidson RN, Russo R. Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin Infect Dis. 1994 Sep;19(3):560–560. [PubMed]
  • de Bruijn MH, Barker DC. Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA. Acta Trop. 1992 Sep;52(1):45–58. [PubMed]
  • de Brujin MH, Labrada LA, Smyth AJ, Santrich C, Barker DC. A comparative study of diagnosis by the polymerase chain reaction and by current clinical methods using biopsies from Colombian patients with suspected leishmaniasis. Trop Med Parasitol. 1993 Sep;44(3):201–207. [PubMed]
  • Dedet JP, Lambert M, Pratlong F. Leishmanioses et infection par le virus de l'immunodéficience humaine. Presse Med. 1995 Jun 17;24(22):1036–1040. [PubMed]
  • Dedet JP, Roche B, Pratlong F, Cales-Quist D, Jouannelle J, Benichou JC, Huerre M. Diffuse cutaneous infection caused by a presumed monoxenous trypanosomatid in a patient infected with HIV. Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):644–646. [PubMed]
  • de la Loma A, Alvar J, Martinez Galiano E, Blázquez J, Alcalá Muñoz A, Nájera R. Leishmaniasis or AIDS? Trans R Soc Trop Med Hyg. 1985;79(3):421–422. [PubMed]
  • Dellamonica P, Bernard E, Le Fichoux Y, Politano S, Carles M, Durand J, Mondain V. Allopurinol for treatment of visceral leishmaniasis in patients with AIDS. J Infect Dis. 1989 Nov;160(5):904–905. [PubMed]
  • Dereure J, Reynes J, Pratlong F, Lamaury I, Rioux JA, Janbon F, Dedet JP. Visceral leishmaniasis in HIV-infected patients in the south of France. Bull World Health Organ. 1995;73(2):245–246. [PubMed]
  • Desjeux P. Human leishmaniases: epidemiology and public health aspects. World Health Stat Q. 1992;45(2-3):267–275. [PubMed]
  • Dietze R, Milan EP, Berman JD, Grogl M, Falqueto A, Feitosa TF, Luz KG, Suassuna FA, Marinho LA, Ksionski G. Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion). Clin Infect Dis. 1993 Dec;17(6):981–986. [PubMed]
  • Easterbrook MD, Levy MH, Gomez AM, Turco SJ, Epand RM, Rosenthal KL. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):496–505. [PubMed]
  • Echevarría J, Campos P, Chang J, Cuéllar L, Gotuzzo E, Paz L, Llanos-Cuentas A. Mucocutaneous leishmaniasis and AIDS: case report. Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):186–186. [PubMed]
  • el-Hassan AM, Zijlstra EE, Meredith SE, Ghalib HW, Ismail A. Identification of Leishmania donovani using a polymerase chain reaction in patient and animal material obtained from an area of endemic kala-azar in the Sudan. Acta Trop. 1993 Oct;55(1-2):87–90. [PubMed]
  • el-Safi SH, Peters W, Evans DA. Studies on the leishmaniases in the Sudan. 3. Clinical and parasitological studies on visceral and mucosal leishmaniasis. Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):465–470. [PubMed]
  • Eresh S, McCallum SM, Barker DC. Identification and diagnosis of Leishmania mexicana complex isolates by polymerase chain reaction. Parasitology. 1994 Nov;109(Pt 4):423–433. [PubMed]
  • España A, Hermida JM, Montilla P, Buzón L. Leishmaniasis cutánea y sistémica con infección por virus herpes en un paciente con SIDA. Rev Clin Esp. 1990 Nov;187(8):437–437. [PubMed]
  • Fernández-Guerrero ML, Aguado JM, Buzón L, Barros C, Montalbán C, Martín T, Bouza E. Visceral leishmaniasis in immunocompromised hosts. Am J Med. 1987 Dec;83(6):1098–1102. [PubMed]
  • Fillola G, Corberand JX, Laharrague PF, Levenes H, Massip P, Recco P. Peripheral intramonocytic leishmanias in an AIDS patient. J Clin Microbiol. 1992 Dec;30(12):3284–3285. [PMC free article] [PubMed]
  • Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH, Fauci AS. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2365–2368. [PubMed]
  • Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science. 1987 Nov 6;238(4828):800–802. [PubMed]
  • Franco-Vicario R, Beltrán de Heredia JM, Rojo P, Hermosa C. Leishmaniosis asociada al síndrome de la inmunodeficiencia adquirida. Med Clin (Barc) 1987 Apr 11;88(14):565–566. [PubMed]
  • Galvão-Castro B, Sá Ferreira JA, Marzochi KF, Marzochi MC, Coutinho SG, Lambert PH. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis. Clin Exp Immunol. 1984 Apr;56(1):58–66. [PubMed]
  • García M, de Andrés RM, Santillana T, Orejas B. Leishmaniasis visceral con afectación intestinal en paciente con SIDA. Enferm Infecc Microbiol Clin. 1994 Oct;12(8):415–416. [PubMed]
  • Gari-Toussaint M, Leliévre A, Marty P, Le Fichoux Y. Contribution of serological tests to the diagnosis of visceral leishmaniasis in patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg. 1994 May-Jun;88(3):301–302. [PubMed]
  • Gasser RA, Jr, Magill AJ, Oster CN, Franke ED, Grögl M, Berman JD. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis. 1994 Jan;18(1):83–90. [PubMed]
  • Gillis D, Klaus S, Schnur LF, Piscopos P, Maayan S, Okon E, Engelhard D. Diffusely disseminated cutaneous Leishmania major infection in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1995 Mar;14(3):247–249. [PubMed]
  • Golino A, Duncan JM, Zeluff B, DePriest J, McAllister HA, Radovancevic B, Frazier OH. Leishmaniasis in a heart transplant patient. J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):820–823. [PubMed]
  • González-Anglada MI, Peña JM, Barbado FJ, González JJ, Redondo C, Galera C, Nistal M, Vázquez JJ. Two cases of laryngeal leishmaniasis in patients infected with HIV. Eur J Clin Microbiol Infect Dis. 1994 Jun;13(6):509–511. [PubMed]
  • de Górgolas M, Castrillo JM, Fernández Guerrero ML. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma. Clin Infect Dis. 1993 Jul;17(1):56–58. [PubMed]
  • de Gorgolas M, Miles MA. Visceral leishmaniasis and AIDS. Nature. 1994 Dec 22;372(6508):734–734. [PubMed]
  • Gradoni L, Gramiccia M. Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today. 1994 Jul;10(7):264–267. [PubMed]
  • Cryan B, Flynn J, Garvey M, O'Gorman T. Aeromonas associated diarrhoea in an otherwise healthy 70-year-old man. J Infect. 1990 Mar;20(2):169–170. [PubMed]
  • Gradoni L, Gramiccia M, Léger N, Pesson B, Madulo-Leblond G, Killick-Kendrick R, Killick-Kendrick M, Walton BC. Isoenzyme characterization of Leishmania from man, dog and sandflies in the Maltese islands. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):217–219. [PubMed]
  • Gradoni L, Guaraldi G, Codeluppi M, Scalone A, Rivasi F. Gastric localization of Leishmania in a patient with acquired immunodeficiency syndrome. A case report. APMIS. 1995 Jan;103(1):25–28. [PubMed]
  • Gradoni L, Scalone A, Gramiccia M. HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections. Trans R Soc Trop Med Hyg. 1993 Jan-Feb;87(1):94–96. [PubMed]
  • Gramiccia M, Ben-Ismail R, Gradoni L, Ben Rachid MS, Ben Said M. A Leishmania infantum enzymatic variant, causative agent of cutaneous leishmaniasis in north Tunisia. Trans R Soc Trop Med Hyg. 1991 May-Jun;85(3):370–371. [PubMed]
  • Gramiccia M, Bettini S, Gradoni L, Ciarmoli P, Verrilli ML, Loddo S, Cicalò C. Leishmaniasis in Sardinia. 5. Leishmanin reaction in the human population of a focus of low endemicity of canine leishmaniasis. Trans R Soc Trop Med Hyg. 1990 May-Jun;84(3):371–374. [PubMed]
  • Gramiccia M, Gradoni L, di Martino L, Romano R, Ercolini D. Two syntopic zymodemes of Leishmania infantum cause human and canine visceral leishmaniasis in the Naples area, Italy. Acta Trop. 1992 Apr;50(4):357–359. [PubMed]
  • Gramiccia M, Gradoni L, Troiani M. HIV-Leishmania co-infections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients. Trans R Soc Trop Med Hyg. 1992 Mar-Apr;86(2):161–163. [PubMed]
  • Gramiccia M, Gradoni L, Troiani M. Heterogeneity among zymodemes of Leishmania infantum from HIV-positive patients with visceral leishmaniasis in south Italy. FEMS Microbiol Lett. 1995 Apr 15;128(1):33–38. [PubMed]
  • Grau JM, Bosch X, Salgado AC, Urbano-Márquez A. Human immunodeficiency virus (HIV) and aplastic anemia. Ann Intern Med. 1989 Apr 1;110(7):576–577. [PubMed]
  • Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sékaly RP, Fauci AS. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science. 1994 Jul 8;265(5169):248–252. [PubMed]
  • Grogl M, Daugirda JL, Hoover DL, Magill AJ, Berman JD. Survivability and infectivity of viscerotropic Leishmania tropica from Operation Desert Storm participants in human blood products maintained under blood bank conditions. Am J Trop Med Hyg. 1993 Sep;49(3):308–315. [PubMed]
  • Grogl M, Thomason TN, Franke ED. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg. 1992 Jul;47(1):117–126. [PubMed]
  • Guarino A, Castaldo A, Di Martino L, Rubino A, Gaeta GB, Gradoni L. Visceral leishmaniasis in a child with HIV-1 infection. Eur J Pediatr. 1994 Apr;153(4):301–302. [PubMed]
  • Guevara P, Ramírez JL, Rojas E, Scorza JV, González N, Añez N. Leishmania braziliensis in blood 30 years after cure. Lancet. 1993 May 22;341(8856):1341–1341. [PubMed]
  • Gutiérrez-Macías A, Alonso-Alonso JJ, Aguirre-Errasti C. Esophageal leishmaniasis in a patient infected with the human immunodeficiency virus. Clin Infect Dis. 1995 Jul;21(1):229–230. [PubMed]
  • Haldar JP, Ghose S, Saha KC, Ghose AC. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun. 1983 Nov;42(2):702–707. [PMC free article] [PubMed]
  • Hernández D, Rodríguez N, Martínez C, García L, Convit J. Leishmania braziliensis causing visceral leishmaniasis in a patient with human immunodeficiency virus infection, identified with the aid of the polymerase chain reaction. Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):627–628. [PubMed]
  • Hernández DE, Oliver M, Martínez C, Planas G. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS). Int J Dermatol. 1995 Feb;34(2):114–115. [PubMed]
  • Hernández DE, Rodriguez N, Wessolossky M, Convit J. Visceral leishmaniasis due to a Leishmania variant that shares kinetoplast DNA sequences with Leishmania braziliensis and Leishmania mexicana in a patient infected with human immunodeficiency virus: identification of the Leishmania species with use of the polymerase chain reaction. Clin Infect Dis. 1995 Sep;21(3):701–702. [PubMed]
  • Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 1992 Mar;46(3):296–306. [PubMed]
  • Heudier P, Taillan B, Garnier G, Marty P, Fuzibet JG, Dujardin P. Localisation pulmonaire d'une leishmaniose viscérale au cours de l'infection par le VIH. Presse Med. 1993 Jun 19;22(22):1060–1060. [PubMed]
  • Jeannel D, Tuppin P, Brucker G, Danis M, Gentilini M. Imported and autochthonous kala-azar in France. BMJ. 1991 Aug 10;303(6798):336–338. [PMC free article] [PubMed]
  • Jha TK. Evaluation of allopurinol in the treatment of kala-azar occurring in North Bihar, India. Trans R Soc Trop Med Hyg. 1983;77(2):204–207. [PubMed]
  • Jiménez M, Ferrer-Dufol M, Cañavate C, Gutiérrez-Solar B, Molina R, Laguna F, López-Vélez R, Cercenado E, Daudén E, Blázquez J, et al. Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiol Lett. 1995 Sep 1;131(2):197–204. [PubMed]
  • Jiménez MI, Laguna F, de la Torré F, Solís F, Pratlong F, Alvar J. New Leishmania (Leishmania) infantum zymodemes responsible for visceral leishmaniasis in patients co-infected with HIV in Spain. Trans R Soc Trop Med Hyg. 1995 Jan-Feb;89(1):33–33. [PubMed]
  • Kager PA, Rees PH, Wellde BT, Hockmeyer WT, Lyerly WH. Allopurinol in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1981;75(4):556–559. [PubMed]
  • Kalter DC. Laboratory tests for the diagnosis and evaluation of leishmaniasis. Dermatol Clin. 1994 Jan;12(1):37–50. [PubMed]
  • Kar K. Serodiagnosis of leishmaniasis. Crit Rev Microbiol. 1995;21(2):123–152. [PubMed]
  • Kemp M, Hey AS, Kurtzhals JA, Christensen CB, Gaafar A, Mustafa MD, Kordofani AA, Ismail A, Kharazmi A, Theander TG. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin Exp Immunol. 1994 Jun;96(3):410–415. [PubMed]
  • Kemp M, Kurtzhals JA, Bendtzen K, Poulsen LK, Hansen MB, Koech DK, Kharazmi A, Theander TG. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun. 1993 Mar;61(3):1069–1073. [PMC free article] [PubMed]
  • Kohanteb J, Ardehali SM, Rezai HR. Detection of Leishmania donovani soluble antigen and antibody in the urine of visceral leishmaniasis patients. Trans R Soc Trop Med Hyg. 1987;81(4):578–580. [PubMed]
  • Kurtzhals JA, Hey AS, Jardim A, Kemp M, Schaefer KU, Odera EO, Christensen CB, Githure JI, Olafson RW, Theander TG, et al. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol. 1994 Jun;96(3):416–421. [PubMed]
  • Lafeuillade A, Chaffanjon P, Delbeke E, Quilichini R. Maintenance itraconazole for visceral leishmaniasis in HIV infection. Am J Med. 1992 Apr;92(4):449–449. [PubMed]
  • Laguna F, García-Samaniego J, Moreno V, González-Lahoz JM. Prevalence of gastrointestinal leishmaniasis in Spanish HIV-positive patients with digestive symptoms. Am J Gastroenterol. 1994 Sep;89(9):1606–1606. [PubMed]
  • Laguna F, García-Samaniego J, Soriano V, Valencia E, Redondo C, Alonso MJ, González-Lahoz JM. Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis. 1994 Jul;19(1):48–53. [PubMed]
  • Laguna F, López-Vélez R, Soriano V, Montilla P, Alvar J, González-Lahoz JM. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV. J Infect. 1994 May;28(3):255–259. [PubMed]
  • Laguna F, Torre-Cisneros J, Moreno V, Villanueva JL, Valencia E. Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1995 Sep;21(3):711–712. [PubMed]
  • Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. [PubMed]
  • Laskay T, Mikó TL, Negesse Y, Solbach W, Röllinghoff M, Frommel D. Detection of cutaneous Leishmania infection in paraffin-embedded skin biopsies using the polymerase chain reaction. Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):273–275. [PubMed]
  • Lazanas MC, Tsekes GA, Papandreou S, Harhalakis N, Scandali A, Nikiforakis E, Saroglou G. Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds. AIDS. 1993 Jul;7(7):1018–1019. [PubMed]
  • Liew FY, O'Donnell CA. Immunology of leishmaniasis. Adv Parasitol. 1993;32:161–259. [PubMed]
  • Lopez Dupla M, Gil Aguado A, Lavilla Uriol P, Pintado Garcia V, Valencia Ortega E, Martinez Martinez P, Garcia-Puig J. Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases. J Antimicrob Chemother. 1993 Oct;32(4):657–659. [PubMed]
  • Lopez M, Inga R, Cangalaya M, Echevarria J, Llanos-Cuentas A, Orrego C, Arevalo J. Diagnosis of Leishmania using the polymerase chain reaction: a simplified procedure for field work. Am J Trop Med Hyg. 1993 Sep;49(3):348–356. [PubMed]
  • López-Vélez R, Laguna F, Alvar J, Pérez-Molina JA, Molina R, Martinez P, Villarrubia J. Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients. J Clin Microbiol. 1995 Apr;33(4):937–939. [PMC free article] [PubMed]
  • Lortholary O, Mechali D, Christiaens D, Gougerot Pocidalo M, Brandely M, Babinet P. Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS. Rev Infect Dis. 1990 Mar-Apr;12(2):370–371. [PubMed]
  • Ma DD, Concannon AJ, Hayes J. Fatal leishmaniasis in renal-transport patient. Lancet. 1979 Aug 11;2(8137):311–312. [PubMed]
  • Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 1990 Sep;71(1):38–45. [PubMed]
  • Machado ES, Braga M da P, Da Cruz AM, Coutinho SG, Vieira AR, Rutowitsch MS, Cuzzi-Maya T, Grimaldi júnior G, Menezes JA. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report. Mem Inst Oswaldo Cruz. 1992 Oct-Dec;87(4):487–492. [PubMed]
  • Maggi E, Mazzetti M, Ravina A, Annunziato F, de Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, del Prete G, et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994 Jul 8;265(5169):244–248. [PubMed]
  • Magill AJ, Grögl M, Gasser RA, Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med. 1993 May 13;328(19):1383–1387. [PubMed]
  • Malek Hosseini SA, Javid R, Salahi H, Nezakatgoo N, Ahmad E, Ghahramani N. A case report of Kala-Azar in a kidney transplant patient. Transplant Proc. 1995 Oct;27(5):2715–2715. [PubMed]
  • Martinez JE, Alba, Arias L, Escobar MA, Saravia NG. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination. Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):392–394. [PubMed]
  • Martínez P, de la Vega E, Laguna F, Soriano V, Puente S, Moreno V, Sentchordi MJ, García-Aguado C, González-Lahoz J. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS. 1993 Feb;7(2):227–230. [PubMed]
  • Martínez Fernández R, García Díaz JD, Gutiérrez Sánchez J, Riopérez Carmena E, Valdivieso Varela L, Alonso Navas F. Leishmaniasis visceral en pacientes adictos a drogas por vía parenteral, VIH positivos. Med Clin (Barc) 1987 Mar 28;88(12):509–511. [PubMed]
  • Marty P, Fuzibet JG, Pratlong F, Quinsat D, Gari-Toussaint M, Dor JF, Le Fichoux Y, Rioux JA. Leishmaniose viscérale causée par une souche dermotrope de Leishmania infantum chez un sidéen. Bull Soc Pathol Exot. 1991;84(4):365–367. [PubMed]
  • Marty P, Le Fichoux Y, Giordana D, Brugnetti A. Leishmanin reaction in the human population of a highly endemic focus of canine leishmaniasis in Alpes-Maritimes, France. Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):249–250. [PubMed]
  • Marty P, Le Fichoux Y, Pratlong F, Gari-Toussaint M. Human visceral leishmaniasis in Alpes-Maritimes, France: epidemiological characteristics for the period 1985-1992. Trans R Soc Trop Med Hyg. 1994 Jan-Feb;88(1):33–34. [PubMed]
  • Marty P, Léger I, Albertini M, Gari-Toussaint M, Tommasi C, Manassero J, Le Fichoux Y, Mariani R. La leishmaniose viscérale infantile dans les alpes-maritimes de 1985 a 1992. Bull Soc Pathol Exot. 1994;87(2):105–109. [PubMed]
  • Mary C, Lamouroux D, Dunan S, Quilici M. Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. Am J Trop Med Hyg. 1992 Dec;47(6):764–771. [PubMed]
  • Matheron S, Cabié A, Parquin F, Mayaud C, Roux P, Antoine M, Chougnet C, Coulaud JP. Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS. 1992 Feb;6(2):238–240. [PubMed]
  • McBride MO, Fisher M, Skinner CJ, Golden R, Main J. An unusual gastrointestinal presentation of leishmaniasis. Scand J Infect Dis. 1995;27(3):297–298. [PubMed]
  • McBride M, Linney M, Claydon EJ, Weber J. Visceral leishmaniasis following treatment with liposomal amphotericin B. Clin Infect Dis. 1994 Aug;19(2):362–362. [PubMed]
  • McGhee RB, Cosgrove WB. Biology and physiology of the lower Trypanosomatidae. Microbiol Rev. 1980 Mar;44(1):140–173. [PMC free article] [PubMed]
  • Mebrahtu YB, Hendricks LD, Oster CN, Lawyer PG, Perkins PV, Pamba H, Koech D, Roberts CR. Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya. Am J Trop Med Hyg. 1993 Apr;48(4):530–535. [PubMed]
  • Mebrahtu YB, Lawyer PG, Pamba H, Koech D, Perkins PV, Roberts CR, Were JB, Hendricks LD. Biochemical characterization and zymodeme classification of Leishmania isolates from patients, vectors, and reservoir hosts in Kenya. Am J Trop Med Hyg. 1992 Dec;47(6):852–892. [PubMed]
  • Diego Mediavilla J, Omar M, Jiménez-Alonso J, Miranda C, Aliaga L. Leishmaniasis visceral con afectación de intestino delgado y colon en un enfermo con infección por HIV. Enferm Infecc Microbiol Clin. 1995 Jun-Jul;13(6):377–378. [PubMed]
  • Medrano FJ, Hernández-Quero J, Jiménez E, Pineda JA, Rivero A, Sánchez-Quijano A, Velez ID, Viciana P, Castillo R, Reyes MJ, et al. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS. 1992 Dec;6(12):1499–1503. [PubMed]
  • Medrano FJ, Jiménez-Mejías E, Calderón E, Regordan C, Leal M. An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1-infected individuals. AIDS. 1993 Oct;7(10):1399–1399. [PubMed]
  • Meller-Melloul C, Farnarier C, Dunan S, Faugere B, Franck J, Mary C, Bongrand P, Quilici M, Kaplanski S. Evidence of subjects sensitized to Leishmania infantum on the French Mediterranean coast: differences in gamma interferon production between this population and visceral leishmaniasis patients. Parasite Immunol. 1991 Sep;13(5):531–536. [PubMed]
  • Mendonca SC, De Luca PM, Mayrink W, Restom TG, Conceicao-Silva F, Da-Cruz AM, Bertho AL, Da Costa CA, Genaro O, Toledo VP, et al. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis. Am J Trop Med Hyg. 1995 Aug;53(2):195–201. [PubMed]
  • Meredith SE, Zijlstra EE, Schoone GJ, Kroon CC, van Eys GJ, Schaeffer KU, el-Hassan AM, Lawyer PG. Development and application of the polymerase chain reaction for the detection and identification of Leishmania parasites in clinical material. Arch Inst Pasteur Tunis. 1993 Jul-Oct;70(3-4):419–431. [PubMed]
  • Michiels JF, Monteil RA, Hofman P, Perrin C, Fuzibet JG, Lefichoux Y, Loubière R. Oral leishmaniasis and Kaposi's sarcoma in an AIDS patient. J Oral Pathol Med. 1994 Jan;23(1):45–46. [PubMed]
  • Miralles ES, Núez M, Hilara Y, Harto A, Moreno R, Ledo A. Mucocutaneous leishmaniasis and HIV. Dermatology. 1994;189(3):275–277. [PubMed]
  • Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun. 1994 Mar;62(3):1058–1063. [PMC free article] [PubMed]
  • Miralles P, Moreno S, Pérez-Tascón M, Cosín J, Díaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1995 Apr;20(4):872–875. [PubMed]
  • Mishra M, Biswas UK, Jha DN, Khan AB. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet. 1992 Nov 21;340(8830):1256–1257. [PubMed]
  • Mishra M, Biswas UK, Jha AM, Khan AB. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet. 1994 Dec 10;344(8937):1599–1600. [PubMed]
  • Molina R, Alvar J. A simple protocol for the indirect xenodiagnosis of Leishmania infantum in the blood of HIV-infected patients. Ann Trop Med Parasitol. 1996 Dec;90(6):639–640. [PubMed]
  • Molina R, Cañavate C, Cercenado E, Laguna F, López-Vélez R, Alvar J. Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. AIDS. 1994 Feb;8(2):277–279. [PubMed]
  • Molina R, López-Vélez R, Gutiérrez-Solar B, Jiménez I, Alvar J. Isolation of Leishmania infantum from the blood of a patient with AIDS using sandflies. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):516–516. [PubMed]
  • Mondain-Miton V, Toussaint-Gari M, Hofman P, Marty P, Carles M, De Salvador F, Miton F, Le Fichoux Y, Dellamonica P. Atypical leishmaniasis in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1995 Sep;21(3):663–665. [PubMed]
  • Montalban C, Calleja JL, Erice A, Laguna F, Clotet B, Podzamczer D, Cobo J, Mallolas J, Yebra M, Gallego A. Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS. J Infect. 1990 Nov;21(3):261–270. [PubMed]
  • Montalban C, Martinez-Fernandez R, Calleja JL, Garcia-Diaz JD, Rubio R, Dronda F, Moreno S, Yebra M, Barros C, Cobo J, et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis. 1989 Jul-Aug;11(4):655–660. [PubMed]
  • Mora A, Borrell M, Galofré J, Grau JM. Alopurinol en el tratamiento de pacientes infectados por el VIH con leishmaniasis visceral. Enferm Infecc Microbiol Clin. 1990 Apr;8(4):257–258. [PubMed]
  • Mosier D, Sieburg H. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol Today. 1994 Jul;15(7):332–339. [PubMed]
  • Muigai R, Gatei DG, Shaunak S, Wozniak A, Bryceson AD. Jejunal function and pathology in visceral Leishmaniasis. Lancet. 1983 Aug 27;2(8348):476–479. [PubMed]
  • Murray HW, Granger AM, Mohanty SK. Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-gamma- and interleukin-2-independent. J Infect Dis. 1991 Mar;163(3):622–624. [PubMed]
  • Murray HW, Hariprashad J, Fichtl RE. Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine. Antimicrob Agents Chemother. 1993 Jul;37(7):1504–1505. [PMC free article] [PubMed]
  • Murray HW, Oca MJ, Granger AM, Schreiber RD. Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. J Clin Invest. 1989 Apr;83(4):1253–1257. [PMC free article] [PubMed]
  • Navin TR, Arana FE, de Mérida AM, Arana BA, Castillo AL, Silvers DN. Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am J Trop Med Hyg. 1990 Jan;42(1):36–42. [PubMed]
  • Nuzum E, White F, 3rd, Thakur C, Dietze R, Wages J, Grogl M, Berman J. Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood. J Infect Dis. 1995 Mar;171(3):751–754. [PubMed]
  • Orofino L, Marcen R, Gamez C, Orte L, Lopez-Velez R, Quereda C, Ortuño J. Visceral leishmaniasis in renal transplant patients. Nephrol Dial Transplant. 1992;7(7):651–651. [PubMed]
  • Pampiglione S, Manson-Bahr PE, Giungi F, Giunti G, Parenti A, Canestri Trotti G. Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1974;68(6):447–453. [PubMed]
  • Pampiglione S, Manson-Bahr PE, La Placa M, Borgatti MA, Micheloni F. Studies on Mediterranean leishmaniasis. IV. The leishmanin skin test in cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1976;70(1):62–65. [PubMed]
  • Pampiglione S, Manson-Bahr PE, La Placa M, Borgatti MA, Musumeci S. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg. 1975;69(1):60–68. [PubMed]
  • Perea WA, Ancelle T, Moren A, Nagelkerke M, Sondorp E. Visceral leishmaniasis in southern Sudan. Trans R Soc Trop Med Hyg. 1991 Jan-Feb;85(1):48–53. [PubMed]
  • Perelló-Roso A, López-Aldeguer J, García-Gascó P, Blanes M. Polyarthritis caused by Leishmania in a patient with AIDS. Clin Infect Dis. 1996 Jun;22(6):1113–1114. [PubMed]
  • Pérez-Molina JA, López-Vélez R, Montilla P, Guerrero A. Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients. AIDS. 1996 Feb;10(2):237–238. [PubMed]
  • Peters BS, Fish D, Golden R, Evans DA, Bryceson AD, Pinching AJ. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med. 1990 Nov;77(283):1101–1111. [PubMed]
  • Pharoah PD, Ponnighaus JM, Chavula D, Lucas SB. Two cases of cutaneous leishmaniasis in Malawi. Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):668–670. [PubMed]
  • Pialoux G, Hennequin C, Dupont B, Ravisse P. Cutaneous leishmaniasis in an AIDS patient: cure with itraconazole. J Infect Dis. 1990 Nov;162(5):1221–1222. [PubMed]
  • Piarroux R, Gambarelli F, Dumon H, Fontes M, Dunan S, Mary C, Toga B, Quilici M. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients. J Clin Microbiol. 1994 Mar;32(3):746–749. [PMC free article] [PubMed]
  • Piarroux R, Gambarelli F, Toga B, Dumon H, Fontes M, Dunan S, Quilici M. Interest and reliability of a polymerase chain reaction on bone-marrow samples in the diagnosis of visceral leishmaniasis in AIDS. AIDS. 1996 Apr;10(4):452–453. [PubMed]
  • Pineda JA, Hernández-Quero J, Gallardo JA, López-Ruz MA, Martínez-Pérez MA, Macías J, Lissen E. Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):263–264. [PubMed]
  • Pratlong F, Dedet JP, Marty P, Portús M, Deniau M, Dereure J, Abranches P, Reynes J, Martini A, Lefebvre M, et al. Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis. 1995 Jul;172(1):323–326. [PubMed]
  • Pratlong F, Reynes J, Dereure J, Baixench MT, Marchou B, Lefebvre M, Janbon F. Characterization of Leishmania isolates from two AIDS patients originating from Valencia, Spain. Trans R Soc Trop Med Hyg. 1993 Nov-Dec;87(6):705–706. [PubMed]
  • Pulido F, Rubio R, Costa JR. Visceral leishmaniasis as a cause of diarrhoea in HIV-infected patients. AIDS. 1995 Jun;9(6):661–662. [PubMed]
  • Qu JQ, Zhong L, Masoom-Yasinzai M, Abdur-Rab M, Aksu HS, Reed SG, Chang KP, Gilman-Sachs A. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin. Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):543–545. [PubMed]
  • Rab MA, Evans DA. Leishmania infantum in the Himalayas. Trans R Soc Trop Med Hyg. 1995 Jan-Feb;89(1):27–32. [PubMed]
  • Rab MA, Hassan M, Bux D, Mahmood MT, Evans DA. The isolation and cultivation of Leishmania infantum from apparently normal skin of visceral leishmaniasis patients in northern Pakistan. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):620–621. [PubMed]
  • Raffi F, Merrien D, Le Pape P, Reliquet V. Use of an Itraconazole/allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS. Clin Infect Dis. 1995 Nov;21(5):1338–1339. [PubMed]
  • Rajendran P, Chatterjee SN, Gupta JB. Observations on human bone-marrow for Leishmania donovani. Indian J Pathol Microbiol. 1989 Oct;32(4):282–285. [PubMed]
  • Ravel S, Cuny G, Reynes J, Veas F. A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells. Acta Trop. 1995 Jun;59(3):187–196. [PubMed]
  • Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995;13:151–177. [PubMed]
  • Ribera E, Cucurull E, Ocaña I, Vallespí T, Gasser I, Juste C. Leishmaniasis visceral en pacientes con infección por HIV. Enferm Infecc Microbiol Clin. 1995 Feb;13(2):73–79. [PubMed]
  • Ribera E, Ocaña I, de Otero J, Cortes E, Gasser I, Pahissa A. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med. 1996 May;100(5):496–501. [PubMed]
  • Rioux JA, Moreno G, Lanotte G, Pratlong F, Dereure J, Rispail P. Two episodes of cutaneous leishmaniasis in man caused by different zymodemes of Leishmania infantum s.l. Trans R Soc Trop Med Hyg. 1986;80(6):1004–1005. [PubMed]
  • Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Perieres J. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp. 1990;65(3):111–125. [PubMed]
  • Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Júnior G, Metze K, Lopes ER. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg. 1994 Mar;50(3):261–268. [PubMed]
  • Coura JR, Galvão-Castro B, Grimaldi Júnior G. Disseminated American cutaneous leishmaniasis in a patient with AIDS. Mem Inst Oswaldo Cruz. 1987 Oct-Dec;82(4):581–582. [PubMed]
  • Rodríguez N, Guzman B, Rodas A, Takiff H, Bloom BR, Convit J. Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization. J Clin Microbiol. 1994 Sep;32(9):2246–2252. [PMC free article] [PubMed]
  • Roig P, Cuadrado JM, Benéitez C, Mayol MJ, López M, Navarro V, Nieto A, Bernacer B. Leishmaniasis visceral de localización intestinal en pacientes con infección por el virus de la inmunodeficiencia humana: presentación de dos casos. Rev Clin Esp. 1993 Apr;192(6):271–273. [PubMed]
  • Romeu J, Millà F, Batlle M, Sirera G, Ferrandiz C, Carreres A, Condom MJ, Clotet B. Visceral leishmaniasis involving lung and a cutaneous Kaposi's sarcoma lesion. AIDS. 1991 Oct;5(10):1272–1272. [PubMed]
  • Rosenthal E, Marty P, Pesce A. Leishmania in bronchoalveolar lavage. Ann Intern Med. 1991 Jun 15;114(12):1064–1065. [PubMed]
  • Rosenthal E, Marty P, Poizot-Martin I, Reynes J, Pratlong F, Lafeuillade A, Jaubert D, Boulat O, Dereure J, Gambarelli F, et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):159–162. [PubMed]
  • Rosenthal PJ, Chaisson RE, Hadley WK, Leech JH. Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome. Am J Med. 1988 Feb;84(2):307–309. [PubMed]
  • Sabbatani S, Isuierdo Calzado A, Ferro A, Lopez Goudiaby AM, Borghi V, Zanchetta GP, Varnier OE. Atypical leishmaniasis in an HIV-2-seropositive patient from Guinea-Bissau. AIDS. 1991 Jul;5(7):899–901. [PubMed]
  • Sarmento e Castro R, Horta AA, Vasconcelos O, Coelho H, Granato C, Rocha Marques A. Leishmaniasis visceral en enfermo infectado por VIH-2. Rev Clin Esp. 1995 Aug;195(8):591–592. [PubMed]
  • Salinas G, Valderrama L, Palma G, Montes G, Saravia NG. Deteccion de amastigotas en leishmaniasis cutánea y mucocutanea por el metodo de inmunoperoxidasa, usando anticuerpo policlonal: sensibilidad y especificidad comparadas con metodos convencionales de diagnostico. Mem Inst Oswaldo Cruz. 1989 Jan-Mar;84(1):53–60. [PubMed]
  • del Mar Sanz M, Rubio R, Casillas A, Guijarro C, Costa JR, Martinez R, de Dios Garcia J. Visceral leishmaniasis in HIV-infected patients. AIDS. 1991 Oct;5(10):1272–1274. [PubMed]
  • Saran R, Gupta AK. Supplemented Schneider's Drosophila medium for isolation of Leishmania donovani promastigotes. Ann Trop Med Parasitol. 1988 Aug;82(4):403–404. [PubMed]
  • Saran R, Gupta AK, Prasad LS. A search for Leishmania in normal skin and blood of Kala-Azar patients from Bihar, India. J Commun Dis. 1988 Mar;20(1):89–90. [PubMed]
  • Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, Labrada LA, Goncalves A. Recurrent lesions in human Leishmania braziliensis infection--reactivation or reinfection? Lancet. 1990 Aug 18;336(8712):398–402. [PubMed]
  • Scaglia M, Malfitano A, Douville H, Sacchi P, Gatti S, Gradoni L, Gramiccia M. Dermonodular and visceral leishmaniasis due to Leishmania infantum with a new isoenzyme pattern: report of a case involving a patient with AIDS. Clin Infect Dis. 1996 Feb;22(2):376–377. [PubMed]
  • Scaglia M, Villa M, Gatti S, Gianelli F, Fabio F. Cutaneous leishmaniasis in acquired immunodeficiency syndrome. Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):338–339. [PubMed]
  • Schaefer KU, Schoone GJ, Gachihi GS, Muller AS, Kager PA, Meredith SE. Visceral leishmaniasis: use of the polymerase chain reaction in an epidemiological study in Baringo District, Kenya. Trans R Soc Trop Med Hyg. 1995 Sep-Oct;89(5):492–495. [PubMed]
  • Schiliro G, Russo A, Musumeci S, Sciotto A. Visceral leishmaniasis following a skin lesion in a six-year-old Silician girl. Trans R Soc Trop Med Hyg. 1978;72(6):656–657. [PubMed]
  • Scott JA, Davidson RN, Moody AH, Grant HR, Felmingham D, Scott GM, Olliaro P, Bryceson AD. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):617–619. [PubMed]
  • Scott P. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol. 1991 Nov 1;147(9):3149–3155. [PubMed]
  • Seaman J, Boer C, Wilkinson R, de Jong J, de Wilde E, Sondorp E, Davidson R. Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clin Infect Dis. 1995 Jul;21(1):188–193. [PubMed]
  • Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson AD, Davidson RN. Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis. 1993 Sep;168(3):715–720. [PubMed]
  • Sendino A, Barbado FJ, Mostaza JM, Fernández-Martin J, Larrauri J, Vázquez-Rodriguez JJ. Visceral leishmaniasis with malabsorption syndrome in a patient with acquired immunodeficiency syndrome. Am J Med. 1990 Nov;89(5):673–675. [PubMed]
  • Sharma MC, Gupta AK, Saran R, Sinha SP. The effect of age and sex on incidence of kala-azar. J Commun Dis. 1990 Dec;22(4):277–278. [PubMed]
  • Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today. 1996 Jan;17(1):21–24. [PubMed]
  • Sherwood JA, Gachihi GS, Muigai RK, Skillman DR, Mugo M, Rashid JR, Wasunna KM, Were JB, Kasili SK, Mbugua JM, et al. Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis. Clin Infect Dis. 1994 Dec;19(6):1034–1039. [PubMed]
  • Siddig M, Ghalib H, Shillington DC, Petersen EA. Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosis. Trans R Soc Trop Med Hyg. 1988;82(1):66–68. [PubMed]
  • Sinha R, Datta U, Sehgal S. Importance of bone marrow culture for diagnosis of Kala azar. Scand J Infect Dis. 1993;25(6):787–789. [PubMed]
  • Smith D, Gazzard B, Lindley RP, Darwish A, Reed C, Bryceson AD, Evans DA. Visceral leishmaniasis (kala azar) in a patient with AIDS. AIDS. 1989 Jan;3(1):41–43. [PubMed]
  • Smyth AJ, Ghosh A, Hassan MQ, Basu D, De Bruijn MH, Adhya S, Mallik KK, Barker DC. Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients. Parasitology. 1992 Oct;105(Pt 2):183–192. [PubMed]
  • Squires KE, Rosenkaimer F, Sherwood JA, Forni AL, Were JB, Murray HW. Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. Am J Trop Med Hyg. 1993 May;48(5):666–669. [PubMed]
  • Sundar S, Kumar K, Singh VP. Ketoconazole in visceral leishmaniasis. Lancet. 1990 Dec 22;336(8730):1582–1583. [PubMed]
  • Silva JS, Barral-Netto M, Reed SG. Aggravation of both Trypanosoma cruzi and murine leukemia virus by concomitant infections. Am J Trop Med Hyg. 1993 Nov;49(5):589–597. [PubMed]
  • Taillan B, Marty P, Schneider S, Telle H, Fuzibet JG, Rosenthal E, Rahal A, Lefichoux Y, Dujardin P. Visceral leishmaniasis involving a cutaneous Kaposi's sarcoma lesion and free areas of skin. Eur J Med. 1992 Jul-Aug;1(4):255–255. [PubMed]
  • Tata M, Kumar A, Feiner H. Visceral leishmaniasis in the acquired immunodeficiency syndrome: report of two cases. Hum Pathol. 1993 Dec;24(12):1379–1381. [PubMed]
  • Thakur CP, Kumar M, Pandey AK. Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. Am J Trop Med Hyg. 1991 Oct;45(4):435–441. [PubMed]
  • Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, Kumar M, Verma BB. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):615–616. [PubMed]
  • Tieszen KL, Molyneux DH. Transmission and ecology of trypanosomatid flagellates of water striders (Hemiptera: Gerridae). J Protozool. 1989 Sep-Oct;36(5):519–523. [PubMed]
  • Torre-Cisneros J, Villanueva JL, Kindelan JM, Jurado R, Sanchez-Guijo P. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clin Infect Dis. 1993 Oct;17(4):625–627. [PubMed]
  • Tremblay M, Olivier M, Bernier R. Leishmania and the pathogenesis of HIV infection. Parasitol Today. 1996 Jul;12(7):257–261. [PubMed]
  • Van Voorhis WC. Therapy and prophylaxis of systemic protozoan infections. Drugs. 1990 Aug;40(2):176–202. [PubMed]
  • Villanueva JL, Torre-Cisneros J, Jurado R, Villar A, Montero M, López F, Sánchez-Guijo P, Kindelán JM. Leishmania esophagitis in an AIDS patient: an unusual form of visceral leishmaniasis. Am J Gastroenterol. 1994 Feb;89(2):273–275. [PubMed]
  • Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S. Ketoconazole in treatment of visceral leishmaniasis. Lancet. 1990 Sep 29;336(8718):810–811. [PubMed]
  • Ward RD, Lainson R, Shaw JJ. Some methods for membrane feeding of laboratory reared, neotropical sandflies (Diptera: Psychodidae). Ann Trop Med Parasitol. 1978 Jun;72(3):269–276. [PubMed]
  • Weigle KA, de Dávalos M, Heredia P, Molineros R, Saravia NG, D'Alessandro A. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg. 1987 May;36(3):489–496. [PubMed]
  • Wong B, Gold JW, Brown AE, Lange M, Fried R, Grieco M, Mildvan D, Giron J, Tapper ML, Lerner CW, et al. Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers. Ann Intern Med. 1984 Jan;100(1):36–42. [PubMed]
  • Yebra M, Segovia J, Manzano L, Vargas JA, Bernaldo de Quirós L, Alvar J. Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome. Ann Intern Med. 1988 Mar;108(3):490–491. [PubMed]
  • Zijlstra EE, Ali MS, el-Hassan AM, el-Toum IA, Satti M, Ghalib HW, Kager PA. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):505–507. [PubMed]
  • Zwingenberger K, Harms G, Pedrosa C, Omena S, Sandkamp B, Neifer S. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production. Clin Immunol Immunopathol. 1990 Nov;57(2):242–249. [PubMed]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)